Francisco spent nearly two decades at Pfizer, where he held a series of senior global and regional communications leadership roles. As Head of Global Communications for Pfizer’s Upjohn business, he led communications in support of the combination of Upjohn and Mylan and the creation and launch of Viatris, helping manage communications through a complex, multi-year corporate transformation involving employees and stakeholders around the world. Earlier at Pfizer, he led communications for a global portfolio of more than 350 established medicines representing approximately $17 billion in annual revenue and supported the company’s re-entry into infectious diseases, major loss-of-exclusivity milestones, and global initiatives addressing noncommunicable diseases and access to medicines. 

At Sanofi, Francisco served as Head of Global Rare Disease Franchise Communications, where he led communications supporting the launches of ALTUVIIIO for hemophilia A, Nexviazyme for Pompe disease, and Xenpozyme for ASMD. He also developed and executed global communications strategies addressing complex regulatory, pricing and access, patient engagement, and reputation issues. Under his leadership, Sanofi’s Rare Disease communications program significantly strengthened the franchise’s external visibility, contributing to an approximately 150% increase in share of voice among key competitors from 2022 to 2023.

Most recently, Francisco has served as a strategic communications advisor and Secretariat Representative to healthcare and life sciences organizations, including the Antimicrobial Resistance Industry Alliance (AMRIA), one of the world’s largest private-sector coalitions addressing antimicrobial resistance, representing more than 75 biotechnology, diagnostics, generic, and research-based pharmaceutical companies and industry associations. In this capacity, he provides senior strategic counsel on corporate positioning, executive communications and thought leadership, while developing communications strategies designed to strengthen the Alliance’s visibility, influence, and engagement with key global health stakeholders.

Francisco brings clients the perspective of an advisor who has spent much of his career inside complex, highly regulated global healthcare organizations—combining strategic counsel with a practical understanding of how to navigate cross-functional environments and translate scientific, business, and commercial priorities into communications that build trust and advance organizational objectives.